Evidence map›Paper›PMID 11263497›Full record

ArticleEMBO reports2000

APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export.

K L Neufeld, F Zhang, B R Cullen, R L White

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Tooth number abnormality: from bench to bedside.International journal of oral science · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Protocadherins at the Crossroad of Signaling Pathways.Frontiers in molecular neuroscience · 2020
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

K L NeufeldDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City 84112, USA. kristi.neufeld@genetics.utah.edu
F Zhang
B R Cullen
R L White
Huntsman Cancer Institute · USHoward Hughes Medical Institute · USUniversity of Utah · US

Funding

TCF/LEF function during intestinal maintenance and colon tumorigenesisP01CA073992 · NCI · UNIVERSITY OF UTAH · PI NEKLASON, DEBORAH WOOD · 1998 to 2014
$29.7M
NCI NIH HHS 5PO1 CA73992-02NCI NIH HHS P01 CA073992
6 · The paper itself

Abstract

Mutational inactivation of adenomatous polyposis coli (APC) initiates most colon carcinomas. APC functions include targeting cytoplasmic beta-catenin, a Wnt pathway mediator, for proteolysis. Although APC shuttles between cytoplasm and nucleus, the role of nuclear APC protein, particularly with respect to nuclear beta-catenin levels and activity, remains unclear. Here, we demonstrate that APC lacking functional nuclear localization signals (NLSs) or nuclear export signals (NESs) does not effectively downregulate nuclear beta-catenin levels; neither does wild-type APC when nuclear export is blocked. While APC bearing mutated NLSs could not downregulate beta-catenin-mediated transcriptional activation, APC lacking NESs remained active. Consistent with the hypothesis that nuclear APC lacking NESs can inhibit beta-catenin function by sequestration, we show that endogenous APC and beta-catenin proteins interact within the nucleus. These data demonstrate that nuclear APC binding to beta-catenin, and then inducing its nuclear export, plays a critical role in the control of nuclear beta-catenin levels and activity.

Indexed as

Down-RegulationTrans-ActivatorsAdenomatous Polyposis ColiAntibiotics, Antineoplasticbeta CateninBlotting, WesternCell LineCell NucleusCloning, MolecularColonic NeoplasmsCytoplasmCytoskeletal ProteinsDNA-Binding ProteinsFatty Acids, UnsaturatedHumansLymphoid Enhancer-Binding Factor 1Antibiotics, Antineoplasticbeta CateninCTNNB1 protein, humanCytoskeletal ProteinsDNA-Binding ProteinsFatty Acids, Unsaturatedleptomycin BLymphoid Enhancer-Binding Factor 1Trans-ActivatorsTranscription Factors

Identifiers

PMID11263497
PMCPMC1083789
OpenAlexW2053029064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.